Diagnosis and Management of Hyperandrogenism

Nikolaou D, Gilling-Smith C. Hirsutism. Curr Obstet Gynaecol 2005;15:174–82

Rosenfield RL. Clinical practice. Hirsutism N Engl J Med 2005;353:2578–88

Hahn S, Kuehnel W, Tan S, et al. Diagnostic value of calculated testosterone indices in the assessment of polycystic ovary syndrome. Clin Chem Lab Med 2007;45:202–7.

Azziz R. The evaluation and management of hirsutism. Obstet Gynecol 2003;101(5 Pt 1):995–1007.

Sheehan MT. Polycystic ovarian syndrome: diagnosis and management. ClinMed Res 2004;2:13–27.

Chang RJ. A practical approach to the diagnosis of polycystic ovary syndrome.Am J Obstet Gynecol 2004;191:713–7

Barbieri RL, Makris A, Ryan KJ. Insulin stimulates androgen accumulation in incubations of human ovarian stroma and theca. Obstet Gynecol 1984;64(3 Suppl):73S–80S

Practice Committee of the American Society for Reproductive Medicine. The evaluation and treatment of androgen excess. Fertil Steril 2006;86(5 Suppl): S241–7.

Moran C. Nonclassic adrenal hyperplasia. Fertil Steril 2006;86 Suppl 1:S3

Ross EJ, Linch DC. Cushing’s syndrome—killing disease: discriminatory value of signs and symptoms aiding early diagnosis. Lancet 1982;2:646–9.

Kaltsas GA, Korbonits M, Isidori AM, et al. How common are polycystic ovaries and the polycystic ovarian syndrome in women with Cushing’s syndrome? Clin Endocrinol 2000;53:493–500.)

Gilling-Smith C. Hirsutism. Curr Obstet Gynaecol 2002;12:144–9.

Danilowics K, Albiger N, Vanegas M, et al. Androgen-secreting adrenal adenomas. Obstet Gynecol 2002;100(5 Pt 2):1099–102

Escobar-Morreale HF. Macroprolactinemia in women presenting with hyperandrogenic symptoms: implications for the management of polycystic ovary syndrome. Fertil Steril 2004;82:1697–9.